Novel Target For Developing Drugs That Block The Induction Of Tinnitus
An epilepsy drug shows promise in an animal model at preventing tinnitus from developing after exposure to loud noise, according to a new study by researchers at the University of Pittsburgh School of Medicine. The findings, reported this week in the early online version of the Proceedings of the National Academy of Sciences, reveal for the first time the reason the chronic and sometimes debilitating condition occurs...
Vaibhav Kumar Jain, Vivek Singh, Vikas Kannaujia, Priyadarshini Mishra, Rajendra Vishnu Phadke, Kumudini SharmaIndian Journal of Ophthalmology 2018 66(5):714-717 This case series aimed to review the significance of revisiting papilledema after successful cerebral venous sinus thrombosis (CVST) management with sinus angioplasty. Four patients presented with blurring and transient obscuration of vision with papilledema, headache, tinnitus, and vomiting. On magnetic resonance venography and digital subtraction angiography, chronic transverse sinus thrombosis was diagnosed for which patients underwent endovascular interventio...
Medicine made from the cannabis plant for severe seizures in children with epilepsy has moved one step closer to U.S. approval
An FDA advisory committee has voted to support approval of a formulation of cannabidiol as an adjunctive treatment for Lennox-Gastaut syndrome and Dravet syndrome in patients 2 years of age or older.Medscape Medical News
Epidiolex was developed to treat two rare and devastating forms of the disease. It contains a chemical compound found in marijuana but not the one that makes people high.
(MedPage Today) -- Cannabidiol medication would be first cannabis-derived drug approved in U.S.
A FDA advisory committee unanimously approved an experimental drug made from marijuana to treat seizures associated rare epilepsy affecting children.
The drug, Epidiolex, was developed by London's GW Pharmaceuticals and is a pharmaceutical-grade form of cannabidiol, or CBD, an oil found in marijuana plants. GW grows the plant in greenhouses and purifies out the CBD.
Conclusion: While a rare finding, interictal PET hypermetabolism does occur, may help identify epileptogenic zones, and assessment to reveal it should be made by concomitant use of surface EEG during PET scans.Pediatr Neurosurg
(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma.
A US Food and Drug Administration advisory committee on Thursday unanimously recommended approval of an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the United States.